|
Showing the most relevant articles for your search:NASDAQ:AFFX | Date | Time | Source | Headline | Symbol | Company | | 01/28/2009 | 4:49PM | Edgar (US Regulatory) | Current report filing (8-K) | NASDAQ:AFFX | Affymetrix, Inc. |
| 01/09/2009 | 6:41PM | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:AFFX | Affymetrix, Inc. |
| 01/08/2009 | 4:00PM | Business Wire | Affymetrix to Webcast Presentation at JPMorgan Healthcare Conference | NASDAQ:AFFX | Affymetrix, Inc. |
| 12/11/2008 | 4:21PM | Edgar (US Regulatory) | Current report filing (8-K) | NASDAQ:AFFX | Affymetrix, Inc. |
| 12/09/2008 | 8:00AM | Business Wire | Affymetrix Technology Powers Cincinnati Children’s Hospital’s Innovative Test for Jaundice | NASDAQ:AFFX | Affymetrix, Inc. |
| 12/08/2008 | 8:00AM | Business Wire | Affymetrix Completes Acquisition of Panomics | NASDAQ:AFFX | Affymetrix, Inc. |
| 12/01/2008 | 8:00AM | Business Wire | Researchers Use Affymetrix Technology to Discover Why Some Breast Cancer Patients Resist Tamoxifen | NASDAQ:AFFX | Affymetrix, Inc. |
| 11/26/2008 | 4:30PM | Business Wire | Affymetrix to Webcast Presentation at Piper Jaffray Healthcare Conference | NASDAQ:AFFX | Affymetrix, Inc. |
| 11/13/2008 | 4:27PM | Edgar (US Regulatory) | Current report filing (8-K) | NASDAQ:AFFX | Affymetrix, Inc. |
| 11/11/2008 | 9:00AM | Business Wire | Affymetrix to Acquire Panomics | NASDAQ:AFFX | Affymetrix, Inc. |
| 11/11/2008 | 8:00AM | Business Wire | Affymetrix Announces New Cost-effective Product for Standardizing Drug Metabolism Studies | NASDAQ:AFFX | Affymetrix, Inc. |
| 11/07/2008 | 3:45PM | Edgar (US Regulatory) | Quarterly Report (10-Q) | NASDAQ:AFFX | Affymetrix, Inc. |
| 11/07/2008 | 3:16PM | Edgar (US Regulatory) | Statement of Ownership (SC 13G) | NASDAQ:AFFX | Affymetrix, Inc. |
| 11/07/2008 | 9:00AM | PR Newswire (US) | Beacon Equity Issues Technical Trade Alerts on Market Movers: NOBL, RUTH, MPEL, FLEX, ONNN, AFFX | NASDAQ:AFFX | Affymetrix, Inc. |
| 10/23/2008 | 4:40PM | Edgar (US Regulatory) | Current report filing (8-K) | NASDAQ:AFFX | Affymetrix, Inc. |
| 10/23/2008 | 4:00PM | Business Wire | Affymetrix Reports Third Quarter 2008 Results | NASDAQ:AFFX | Affymetrix, Inc. |
| 10/22/2008 | 6:15PM | Business Wire | Affymetrix Founder and CEO Announces Succession Plan | NASDAQ:AFFX | Affymetrix, Inc. |
| 10/21/2008 | 4:53PM | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:AFFX | Affymetrix, Inc. |
| 10/21/2008 | 4:51PM | Edgar (US Regulatory) | Initial Statement of Beneficial Ownership (3) | NASDAQ:AFFX | Affymetrix, Inc. |
| 10/21/2008 | 9:00AM | PR Newswire (US) | Beacon Equity Issues Technical Trade Alerts on Market Movers: INCY, DRRX, MDRX, NKTR, PRGN, AFFX | NASDAQ:AFFX | Affymetrix, Inc. |
| 10/20/2008 | 4:30PM | Business Wire | Affymetrix Appoints Rick Runkel to Executive Vice President and General Counsel | NASDAQ:AFFX | Affymetrix, Inc. |
| 10/14/2008 | 4:44PM | Edgar (US Regulatory) | Current report filing (8-K) | NASDAQ:AFFX | Affymetrix, Inc. |
| 10/13/2008 | 12:19PM | Marketwired | BellwetherReport.com Analyst Opinions on DISH, AFFX, CNQR and ESRX | NASDAQ:AFFX | Affymetrix, Inc. |
| 10/13/2008 | 5:00AM | Business Wire | Affymetrix Announces Preliminary Third Quarter Revenue | NASDAQ:AFFX | Affymetrix, Inc. |
| 10/07/2008 | 8:00AM | Business Wire | South African Core Lab Adopts Affymetrix Technology for Genomic Studies | NASDAQ:AFFX | Affymetrix, Inc. |
| 10/03/2008 | 8:00AM | Business Wire | Wall Street Journal Selects PhyloChip Developed on the Affymetrix Platform as a Top Technology Innovation | NASDAQ:AFFX | Affymetrix, Inc. |
| 10/01/2008 | 8:00AM | Business Wire | Affymetrix and Medical Prognosis Institute Collaborate to Develop Cancer Treatment Products | NASDAQ:AFFX | Affymetrix, Inc. |
| 09/29/2008 | 8:00AM | Business Wire | Affymetrix' GeneTitan(TM) System Delivers Automatic Answers and Sets New Standard in Genomic Analysis | NASDAQ:AFFX | Affymetrix, Inc. |
| 09/25/2008 | 8:00AM | Business Wire | Wellcome Trust Sanger Institute Uses Affymetrix Technology to Reveal Changes in 800 Cancer Cell Lines | NASDAQ:AFFX | Affymetrix, Inc. |
| 09/16/2008 | 9:00PM | Business Wire | Affymetrix to Webcast Presentation at UBS Global Life Sciences Conference | NASDAQ:AFFX | Affymetrix, Inc. |
|
Showing the most relevant articles for your search:NASDAQ:AFFX |
|